BERWYN, Pa., March 7, 2017 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH). Our investigation concerns potential breach of fiduciary duty and securities claims.
On March 6, 2017, STAT, a news organization focused on medical industry reporting, published an article alleging that NantHealth founder, Patrick Soon-Shiong, had donated $12 million to the University of Utah from three different tax-exempt entities controlled by him under a contract that required the University to funnel most of that money into NantHealth. STAT alleges that the scheme allowed the Company to inflate the number of test orders it reported to investors.
On this news, shares of NantHealth fell 23% to close at 5.50 per share on March 6, 2017.
If you own shares of NantHealth and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, visit: www.maniskas.com. You may also email Mr. Maniskas at firstname.lastname@example.org.
RM LAW, P.C. is a national shareholder litigation firm. RM LAW, P.C. is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rm-law-announces-investigation-of-nanthealth-inc-300419649.html
SOURCE RM LAW, P.C.